BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29886488)

  • 1. Liver Resection for Colorectal Hepatic Metastases after Systemic Chemotherapy and Selective Internal Radiation Therapy with Yttrium-90 Microspheres: A Systematic Review.
    Baltatzis M; Siriwardena AK
    Dig Surg; 2019; 36(4):273-280. PubMed ID: 29886488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study.
    Gibbs P; Gebski V; Van Buskirk M; Thurston K; Cade DN; Van Hazel GA;
    BMC Cancer; 2014 Dec; 14():897. PubMed ID: 25487708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective internal radiation therapy with 90yttrium microspheres for extensive colorectal liver metastases.
    Stubbs RS; Cannan RJ; Mitchell AW
    J Gastrointest Surg; 2001; 5(3):294-302. PubMed ID: 11360053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective internal radiation therapy for liver metastases from colorectal cancer.
    Townsend AR; Chong LC; Karapetis C; Price TJ
    Cancer Treat Rev; 2016 Nov; 50():148-154. PubMed ID: 27690234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable liver-only or liver-dominant metastatic colorectal cancer.
    Dutton SJ; Kenealy N; Love SB; Wasan HS; Sharma RA;
    BMC Cancer; 2014 Jul; 14():497. PubMed ID: 25011439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete eradication of hepatic metastasis from colorectal cancer by Yttrium-90 SIRT.
    Garrean S; Muhs A; Bui JT; Blend MJ; Owens C; Helton WS; Espat NJ
    World J Gastroenterol; 2007 Jun; 13(21):3016-9. PubMed ID: 17589957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective internal radiation therapy for liver metastases from colorectal cancer.
    Townsend A; Price T; Karapetis C
    Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD007045. PubMed ID: 19821394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal sequential approach in colorectal cancer liver metastases: hepatic resection after yttrium-90 selective internal radiation therapy and cetuximab rescue treatment.
    Pini S; Pinto C; Angelelli B; Giampalma E; Blotta A; Di Fabio F; Santini D; Golfieri R; Martoni AA
    Tumori; 2010; 96(1):157-9. PubMed ID: 20437875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective internal radiation therapy (SIRT) with 90Yttrium microspheres for extensive colorectal liver metastases.
    Stubbs RS; Cannan RJ; Mitchell AW
    Hepatogastroenterology; 2001; 48(38):333-7. PubMed ID: 11379303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective internal radiation therapy with yttrium-90 resin microspheres followed by anatomical hepatectomy: A potential curative strategy in advanced hepatocellular carcinoma.
    Feng X; Zhang L; Niu H; Zhang H; Yang L; Wen Y; Chen SY; Shi Y; He Z; Yu L; Wang Y; Huang X; Wang Z; Qin M; Wen X; Zhang Z; Song J; Zheng Z; Yin H; Zhang H; Ma L; Wei J; Wu X; Zhang L; Zhao Y; Lu Q; Xiao H; Liu T; Fang P; Wei L; Gandhi RT; Dong J
    Asia Pac J Clin Oncol; 2024 Apr; 20(2):319-322. PubMed ID: 36658669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I trial of selective internal radiation therapy for chemorefractory colorectal cancer liver metastases progressing after hepatic arterial pump and systemic chemotherapy.
    Sofocleous CT; Garcia AR; Pandit-Taskar N; Do KG; Brody LA; Petre EN; Capanu M; Longing AP; Chou JF; Carrasquillo JA; Kemeny NE
    Clin Colorectal Cancer; 2014 Mar; 13(1):27-36. PubMed ID: 24370352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anatomical basis and histopathological changes resulting from selective internal radiotherapy for liver metastases.
    Wang LM; Jani AR; Hill EJ; Sharma RA
    J Clin Pathol; 2013 Mar; 66(3):205-11. PubMed ID: 23162108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective internal radiation therapy with 90Y microspheres for colorectal liver metastases: single-centre experience with 100 patients.
    Stubbs RS; O'Brien I; Correia MM
    ANZ J Surg; 2006 Aug; 76(8):696-703. PubMed ID: 16916386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of selective internal radiation therapy using yttrium-90 resin microspheres in treating patients with inoperable colorectal liver metastases in the UK.
    Pennington B; Akehurst R; Wasan H; Sangro B; Kennedy AS; Sennfält K; Bester L
    J Med Econ; 2015; 18(10):797-804. PubMed ID: 25941769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicentric phase II clinical trial on intra-arterial hepatic radiotherapy with 90yttrium SIR-spheres in unresectable, colorectal liver metastases refractory to i.v. chemotherapy: preliminary results on toxicity and response rates.
    Mancini R; Carpanese L; Sciuto R; Pizzi G; Golfieri R; Giampalma L; Cappelli A; Galaverni MC; Blotta A; Fiore F; Izzo F; Lastoria S; Mastro A; Di Marzo M; Cagol PP; Gasparini D; Geatti O; Bacchetti S; Pasqual E; Zeuli M; Paoletti G; Garufi C; Cosimelli M;
    In Vivo; 2006; 20(6A):711-4. PubMed ID: 17203751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yttrium-90 microsphere-selective internal radiation therapy with chemotherapy (chemo-SIRT) for colorectal cancer liver metastases: an in vivo double-arm-controlled phase II trial.
    Gulec SA; Pennington K; Wheeler J; Barot TC; Suthar RR; Hall M; Schwartzentruber D
    Am J Clin Oncol; 2013 Oct; 36(5):455-60. PubMed ID: 22643569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful right hepatectomy after four treatments of yttrium-90 microspheres (SIR-Spheres) and concomitant FOLFOX as bridging therapy to resection of colorectal liver metastases.
    Chua TC; Bester L; Akther J; Morris DL
    Anticancer Res; 2010 Jul; 30(7):3005-7. PubMed ID: 20683046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of hepatic resection in metastatic disease to the liver after yttrium-90 therapy.
    Whitney R; Tatum C; Hahl M; Ellis S; Scoggins CR; McMasters K; Martin RC
    J Surg Res; 2011 Apr; 166(2):236-40. PubMed ID: 19691985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma.
    Welsh JS; Kennedy AS; Thomadsen B
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S62-73. PubMed ID: 16979443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors.
    Kuei A; Saab S; Cho SK; Kee ST; Lee EW
    World J Gastroenterol; 2015 Jul; 21(27):8271-83. PubMed ID: 26217079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.